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A B S T R A C T   
This work describes a new successful approach for designing biosensors that detect antibiotics. It makes use of a 
biomimetic strategy, by employing the biochemical target of a given antibiotic as its biorecognition element. This 
principle was tested herein for quinolones, which target DNA gyrase in bacteria. Ciprofloxacin (CIPRO) was 
tested as a representative antibiotic from the quinolone group; the sensitivity of biosensor to this group was 
confirmed by checking the response to another quinolone antibiotic (norfloxacin, NOR) and to a non-quinolone 
antibiotic (ampicillin, AMP). 
The biorecognition element used was DNA gyrase attached by ionic interactions to a carbon support, on a 
working electrode on common screen-printed electrodes (SPEs). The response against antibiotics was tested for 
increasing concentrations of CIPRO, NOR or AMP, and following the subsequent electrical changes by electro-
chemical impedance spectroscopy. The DNAgyrase biosensor showed sensitive responses for CIPRO and NOR, for 
concentrations down to 3.02 nM and 30.2 nM, respectively, with a very wide response range for CRIPRO, up to 
30.2 µM. Its response was also confirmed selective for quinolones, when compared to its response against AMP. 
Further comparison to an immunosensor of similar design (adding antibodies instead of DNA gyrase) was made, 
revealing favourable features for the new biomimetic biosensor with 1.52 nM of limit of detection (LOD). 
Overall, the new approach presented herein is simple and effective for antibiotic detection, displaying a se-
lective response against a given antibiotic group. The use of bacterial machinery as biorecognition element in 
biosensors may also provide a valuable tool to study the mechanism of action in bacterial cells of new drugs. This 
is especially important in the development of new drugs to fight bacterial resistance.   
1. Introduction 
Antibiotics are naturally occurring, semi-synthetic and synthetic 
compounds with antibacterial activity, typically employed for 
improving human and animal health [1], as well as for improving feed 
efficiency and promoting animal/fish growth in farming processes [2,3]. 
They enabled extending the lifetime of humans/animals, but generated 
a vicious cycle of an increasing population and an increasing demand for 
these drugs, both for human and for veterinary purposes [4]. 
The global antibiotic consumption increased by almost 40% from 
2000 to 2015, corresponding to more than 42 billion daily doses [5]. 
Estimates indicate that about 106 000 tons of antibiotics will be 
employed by 2030, and from these about one third correspond to the 
increasing implementation of large-scale intensive farming, in which 
aquaculture [6] is included, typically employing antimicrobials in sub- 
therapeutic levels [4]. Globally, these antibiotics end up in sewages 
and wastewater treatment plants, appearing later in large amounts in 
environmental water, soil and sediments, thereby affecting the sur-
rounding ecosystem [7,8]. 
When these antibiotics meet bacteria in water bodies, new 
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pathogenic strains are being formed that are resistant to these antibiotics 
[9]. Their concentrations are low, ranging from ng/L to µg/L, but they 
compromise the efficiency of antimicrobial therapies by the develop-
ment of resistant genes [10,11]. According to the World Health Orga-
nization (WHO), antibacterial resistance is increasing and becoming a 
global threat to public health [12,13]. 
Thus, it is urgent to fight antibiotic resistance and this should start by 
reducing their release into the environment. This requires constant 
monitoring and controlling of antibiotics in-situ [14], for which low cost 
biosensors are required. This is mostly valuable and interesting for 
aquaculture farmers. They may use biosensors to grant that only the 
minimum amount the antibiotic to terminate the bacterial infection in 
fish is being employed. This procedure is a win/win scenario that re-
duces costs of production and prevents additional contamination of 
environmental waters. 
To this end, this work addresses for the first time in the literature a 
biosensor that uses bacteria machinery to which the antibiotic interacts 
as a biorecognition element. This was never tried out before for antibi-
otics and essentially mimics nature. In essence, antibiotics are organic 
compounds grouped in different classes (Fig. 1), as β-lactams, sulfon-
amides, quinolones, aminoglycosides and tetracyclines, according to 
their chemical structure and mechanism of action [15,16]. Antibiotics 
can inhibit the cell wall synthesis, nucleic acids action, interact with 
protein synthesis or metabolic pathways, and/or disrupt the bacterial 
cell membrane [17]. These different actions are related to the different 
cell targets of the several groups of antibiotics, as shown in Fig. 1. Each 
of these targets give a clue of a biomolecule to which each antibiotic 
group holds high and selective affinity. Thus, its use in a biosensor 
would lead to a selective response against a given group of antibiotics, 
which would provide valuable information, not only for environmental 
monitoring, but also for pharmacological and kinetic studies with new 
drugs under development. 
This novel concept was tested herein for quinolones [18,19], a group 
of synthetic antibiotics that is common in environmental waters 
[20–22]. Ciprofloxacin (CIPRO) is one of the mostly used quinolones 
(Fig. S1), which also displays high stability in soil and wastewater sys-
tems [18,23,24]. It has been linked to the formation of resistant genes 
[25], thereby justifying its urgent monitoring. In terms of mechanism, 
quinolones interfere with bacterial metabolism by interacting with 
bacterial DNA gyrase [26]. This means that quinolone antibiotics 
display a high and selective affinity for DNA gyrase, supporting the use 
of DNA gyrase as a biorecognition element to detect quinolones in bio-
sensors, including CIPRO in particular. 
In the literature, biosensors for CIPRO are assembled with conven-
tional biorecognition elements. These include several compounds, as 
nucleic acid-based biosensors or enzymes/nanoparticles with catalytic 
activity for CIPRO or antibodies [24,27–32]. Overall, there are no pre-
vious works offering a similar approach to the one proposed herein. Yet, 
it is important to highlight that a biosensor with DNAGyrase as bio-
recognition element would be responding to the antibiotic group inter-
acting with this bacterial target, and not only to CIPRO The use of 
bacterial machinery as biorecognition element in biosensors may also 
provide a valuable tool to study the mechanism of action in bacterial 
cells of new drugs. 
This work reports the immobilization of DNA gyrase on carbon 
screen-printed electrodes (C-SPEs) modified with carboxylated carbon 
nanotubes and the evaluation of the resulting electrochemical perfor-
mance. Carbon nanotubes have been used in commercial SPEs for 
improving their electrochemical features. These nanomaterials have 
several electrochemical properties like high surface area, electron-rich 
properties (faster electron transfer kinetics), low residual current, 
readily renewable surface [33] and excellent chemical and thermal 
stability. These features made carbon-based materials very promising 
nanomaterials in different fields of knowledge [34]. 
The cross-response to other antibiotics is evaluated and compared 
with an immunosensor assembled in a similar way. Application to the 
analysis of spiked waters is also described. 
Fig. 1. Overall representation of the different groups of antibiotics and their bacterial cell targets.  
A.R. Cardoso et al.                                                                                                                                                                                                                             
Chemical Engineering Journal 409 (2021) 128135
3
2. Experimental section 
2.1. Apparatus 
Electrochemical readings were made in a potentiostat/galvanostat/ 
impedance analyzer from PalmSens4, controlled by PSTrace electro-
chemistry software. C-SPEs were purchased from Metrohm (DRP-110), 
which contained carbon counter and auxiliary electrodes and a silver 
pseudo-reference electrode printed on a ceramic substrate of 3.4 × 1.0 
× 0.05 cm dimensions; the carbon-working electrode had 4 mm diam-
eter. C-SPEs were linked to the potentiostat via a switch box produced by 
EIH/Porto-Portugal. 
Raman spectra were collected in a Raman DXR from Thermo Sci-
entific, equipped with confocal microscopy. A 532 nm laser was 
employed, at a maximum power of 5 mW, operating with a 50 µm slit, a 
spot size of 0.5 µm and a resolution of 5.5–8.3 cm− 1. 
2.2. Reagents and solutions 
Ultrapure Milli-Q water laboratory grade (conductivity <0.1 µS/cm) 
was used throughout. The chemical reagents used include potassium 
hexacyanoferrate III (K3[Fe(CN)6]), potassium hexacyanoferrate II 
(K4[Fe(CN)6]) trihydrate and sodium acetate, from Riedel-deHäen; p- 
phenylenediamine, carboxylated carbon nanotubes, CIPRO and nor-
floxacin, from Sigma-Aldrich; N′-ethyl-N′-(3-dimethylaminopropyl)car-
bodiimide hydrochloride (EDAC) and ampicillin (AMP), from Alfa 
Aesar; N-hydroxysuccinimide (NHS), from Fluka; N-dimethylformamide 
(DMF) and acetic acid, from Analar Normapur; phosphate buffer saline 
(PBS) and bovine serum albumin (BSA), from Amresco; DNA gyrase and 
anti-enrofloxacin/CIPRO (Ab-ENRO/CIPRO) were obtained from Santa 
Cruz Biotechnology. 
All solutions were prepared in 0.1 M PBS solution, prepared by dis-
solving a commercial tablet in ultrapure water. An amount of about 
1.00 mg of carboxylated carbon nanotubes was suspended in 1.0 ml 
DMF. The EDAC/NHS modification used 0.28 mg/ml EDAC and 0.70 
mg/ml NHS solutions, freshly prepared in PBS. A 0.020 M p-phenyl-
enediamine solution and 0.50 mg/ml were prepared in PBS. The elec-
trical changes were followed by a solution with 5.0 × 10− 3 M K3[Fe 
(CN)6] and 5.0 × 10− 3 M K4[Fe(CN)6], prepared in PBS, pH 7.40. The 
different standards were prepared in 0.1 M acetate buffer with pH 4.00. 
The Gyrase Reaction Buffer (commercial) was composed of 35 mM Tris- 
HCl, 24 mM KCl, 4 mM MgCl2, 2 mM DTT, 1.75 mM ATP, 5 mM sper-
midine, 0.1 mg/ml BSA, and 6.5% glycerol pH 7.50. The BSA solution 
was composed of BSA and PBS. 
2.3. Preparation of electrochemical sensor on carbon screen-printed 
electrodes 
The assembly of the sensor using antibiotic machinery was based on 
our previous works regarding the detection of circulating antibodies for 
Malaria [35] and Zika [36], in which a simple approach was included to 
immobilize the target antigens. Herein, the biorecognition element 
bound to the electrode was DNA gyrase, and antibodies were also used 
but for comparison purposes. 
In detail, C-SPEs were modified as described in Fig. 2. First, 
carboxylated carbon-nanotubes in DMF were dispersed and incubated in 
the working electrode (72 ◦C, for 30 min). Then, the carboxylic groups of 
the carbon nanotubes were activated by incubating EDAC/NHS solu-
tions, freshly mixed, for 1h30m, at room temperature. The next step 
consisted in the incubation of p-phenylenediamine (0.02 M), for 1 h, at 
room temperature, to form an amine layer. 
The biorecognition element was added by incubating the DNA gyrase 
solution (1 µl of DNA gyrase + 6 µl DNA gyrase reaction buffer + 23 µl 
PBS), for 30 min, at room temperature. When antibodies were 
employed, a solution of Ab-ENRO/CIPRO (0.1 mg/ml) was incubated 
(instead of DNA gyrase), for 30 min, at 37 ◦C. Non-specific binding to the 
antibodies was avoided by incubating next a BSA solution, for 1 h, at 
4 ◦C [37]. 
Each step of the assembly of the biosensor (immobilization of carbon 
nanotubes, incubation with EDAC/NHS, p-phenylenediamine and DNA 
Gyrase or antibodies) was followed by washing with Milli-Q water and 
drying with nitrogen. 
The binding of CIPRO was made by incubating standard solutions of 
increasing concentrations. Each standard was let stand for 30 min at 
room temperature, and then this solution was washed out and replaced 
by the iron redox probe to collect the electrochemical data. All assays 
Fig. 2. Schematic representation of the 
modification of the C-SPEs. It starts by a 
common approach by (A) adding 
carboxylated carbon nanotubes, (B) 
modifying these with EDAC/NHS and 
(C) inactivating active carboxyl groups 
with p-phenylenediamine. DNA gyrase 
biosensors are prepared by additional 
incubation of (D) DNA-gyrase for sub-
sequent (E) CIPRO binding. When anti-
bodies are intended as biorecognition, 
the assembly continues after stage (C) 
with the incubation of (F) antibodies, 
followed by (G) BSA incubation to block 
non-specific binding and (H) CIPRO 
binding.   
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were performed in triplicate. 
2.4. Electrochemical procedures 
The electrochemical studies involved Cyclic Voltammetry (CV), 
Electrochemical Impedance Spectroscopy (EIS) and Square Wave Vol-
tammetry (SWV) assays, performed with the iron redox probe solution 
incubated in the 3-electrode system. CV assays were made by scanning 
potentials from − 0.3 to +0.7 V, at 50 mV/s. EIS assays used a sinusoidal 
potential perturbation with amplitude 0.01 V, and 50 frequency values, 
logarithmically distributed from 0.1 to 100,000 Hz. The EIS data was 
fitted to a Randles equivalent circuit using 5.5 PSTrace from PalmSens 
and was analyzed by Nyquist plot. SWV assays were conducted from 
− 0.3 to +0.7 V, with a frequency of 25 Hz and the step height of to 50 
mV. 
Concerning the EIS data, Nyquist plots were used, showing the 
negative imaginary impedance − Z′′ versus the real part of the impedance 
Z′ [38]. This circuit contained Rct, Cdl and Zw elements that represent, 
respectively, charge transfer resistance, double layer capacitance and 
Warburg impedance. The Rct value is extracted by measuring the 
diameter of the semicircle, providing information about the difficulty of 
electron transfer of the ferro/ferricyanide redox probe between the so-
lution and the electrode surface [39]. 
The limit of detection (LOD) was calculated as X + 3σ, where X was 
the average value of the EIS blank signals (obtained in the absence of 
CIPRO) and σ the known standard deviation of EIS blank signal in 
consecutive readings [40]. 
3. Results and discussion 
3.1. Assembly the DNA gyrase biosensor 
The sequential chemical modifications made on the working elec-
trode (Fig. 2) changed the typical electron transfer properties of the 3- 
electrode system. These properties were monitored by following the 
response of a standard iron probe, in CV, EIS and SWV electrochemical 
techniques (Fig. 3), which were also used to confirm the success of such 
modifications. The corresponding electrochemical data may be seen in 
Table 1. 
The first stage consisted in the incubation of carboxylated carbon 
nanotubes (Fig. 2A). Typically, the addition of carbon nanotubes leads 
to a significant increase of the current signals, although the presence of 
carboxyl functions diminishes the conductivity features of these nano-
materials, because the alternated π electron signature has several in-
terruptions along their way. Thus, the changes observed in terms of 
electrochemical performance (Fig. 3) evidenced higher currents in CV 
Fig. 3. Electrochemical CV (A), EIS (B), and SWV (C) follow-up of the sequential modification of the C-SPEs (layers of carboxylated nanotubes, EDAC/NHS, and DNA 
gyrase), along with the Raman spectra for these layers, normalized to G-band and recorded in a later stage (single-wall carbon nanotubes in D are from a different 
batch than in A–C). 
Table 1 
Average values of the electrochemical data obtained in each step of the assembly 
of the biosensor, detailing CV, EIS and SWV generated data.  
Steps of 
Assembly 















117 121 0.240 − 0.008 421 50.0 
Carbon 
nanotubes 
125 − 127 0.240 0.045 53 79.8 
EDAC/NHS 101 − 102 0.240 0.005 173 47.9 
DNA Gyrase 91 − 90 0.297 0.023 336 38.1  
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around ±125 µA and SWV around ±79.8 µA and lower Rct values (in 
EIS) around 53 Ω, being this difference more evident in SWV and EIS 
(Table 1). 
The second stage was the activation of carboxylic groups with EDAC 
reaction to create a highly reactive O-acylisourea intermediate that 
subsequently reacted with NHS (Fig. 2B). This modification was linked 
to decreasing currents in CV (±101 µA) and in SWV (±47.9 µA) and 
increasing Rct in EIS (173 Ω), as an outcome of the introduction of a non- 
conductive polar group. The intermediate underwent a mild reaction 
with an amine group (Fig. 2C), including that from p-phenylenediamine, 
to generate an amined layer on top of the electrode [41]. 
The biorecognition element DNA gyrase (Fig. 2D) was placed on the 
amine layer by direct incubation. In general, amine surfaces are a good 
support for protein binding [42]. In the particular case of DNA gyrase, its 
isoelectric point is 6.8 meaning that negative charges are dominant at 
pH 7.4 (but not very intense) and these charges may undergo ionic in-
teractions with the positively charged amine groups. The presence of 
DNA gyrase on the electrodes yielded lower currents in CV (±91 µA) and 
SWV (38.1 µA) and higher Rct values (336 Ω) than the EDAC/NHS stage 
(Fig. 3 and Table 1), but as the effect of the addition of p-phenylenedi-
amine was not monitored (this monitoring interacted negatively with 
the electrode assembly), this direct comparison to the previous stage 
cannot be made. 
Combining all electrochemical data collected herein (CV, EIS and 
SWV) Table 1, the changes in Rct were clearly more sensitive. Thus, EIS 
was employed in subsequent studies that involved the incubation of 
CIPRO (Fig. 2E, H) to assess its binding features in the form of 
calibrations. 
The chemical modification of the several stages of the electrode as-
sembly were also followed by Raman spectroscopy. The C-SPE had a 
spectra of low intensity with typical G′ and D bands, located at 1581.7 
cm− 1 and 1347.5 cm− 1, respectively. Typically, these correspond, 
respectively, to the tangential stretching mode from graphitic-like ma-
terials and the structural defects in the graphitic sp2 system. The casting 
of nanotubes (single-walled) on this support that were well dispersed 
changed dramatically the Raman spectra. The G and D bands were now 
located at 1589.9 and 1310.3 cm− 1, with the D-band decreasing 
significantly, and a Ǵ band becoming evident, at 2619 cm− 1. Overall, 
this confirmed the presence of the nanotubes on the C-SPE [43]. The 
subsequent addition of the EDAC/NHS and DNA-gyrase did not show a 
significant effect, but indicated a moderate increase of the D-band 
(relatively to the G-band) that signaled a disordered carbon structure (as 
expected). This D-band was now located at 1309.2 and 1308.6 cm− 1, 
respectively. Overall, the Raman spectra confirmed the chemical mod-
ifications occurring at the electrode surface. 
3.2. Electrochemical response to ciprofloxacin 
The analytical performance of the DNA gyrase biosensor was fol-
lowed by casting on the working electrode increasing concentrations of 
CIPRO standard solutions, for 30 min. These solutions ranged from 
0.302 nM to 3.02 mM. After each antibiotic incubation, the electrodes 
were washed and the electrical performance measured by EIS, covering 
the 3-electrode system with the standard iron redox probe. The obtained 
data is shown in Fig. 4, fitted to a Randles equivalent circuit that was 
composed by the resistance of the solution (Rs), the double layer 
capacitance (Cdl), the charge-transfer resistance (Rct) at the electrode 
surface and the Warburg element (W) signalling diffusion. 
Overall, a comparison of all data from the Randles circuit (Table S1) 
indicated that Rct was the dominant variable changing with CIPRO 
concentration, and increasing concentrations of CIPRO yielded 
increasing Rct values (Fig. 4A). This derived from two main aspects. The 
most significant one is related to the non-conductive features of CIPRO, 
which contributed to hinder the charge-transfer properties of the sensing 
layer. The other was much less relevant and accounted the negative 
protonation of some CIPRO species that may exist pH 7.4, which would 
contribute for an electrical reduction of the charge transfer ability of the 
negatively charged iron redox probe. In general, it is likely that most of 
CIPRO species are in zwitterionic form at pH 7.4 and this is why this 
effect of the charge change is small. 
The increasing Rct values exhibited a linear trend against the loga-
rithm CIPRO concentration, with an average slope of 55.2 Ω/decade 
concentration and a minimum squared correlation coefficient of 0.998, 
from 3.02 nM to 0.302 mM (Fig. 4B). Higher concentrations saturated 
the response of the sensing layer, while lower concentrations lead to a 
response that was similar to the blank. The reproducibility of the elec-
trochemical response was excellent, evidencing that the system is 
reproducible considering that RSD values ranged from 2.12, 2.6% and 
0.85%, in 3.02 nM, 3.02 µM and 0.302 mM, respectively. 
The response of the DNA gyrase biosensor also compares favourably 
to other biosensors reported in the literature [44–46]. The limit of 
detection of the DNA gyrase biosensor is 1.52 nM In addition, the 
Fig. 4. Nyquist plots (A) of the calibration of the DNA gyrase biosensor with increasing concentrations of CIPRO standard solutions (0.302 nM–3.02 mM) and the 
corresponding calibration curve (B) with different analytes: CIPRO, NOR and AMP using the Randles circuit, being composed of the following elements: resistance of 
the solution (Rs), the double layer capacitance (Cdl), the charge-transfer resistance (Rct) at the electrode surface and the Warburg element (W) signalling diffusion. 
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construction of this biosensor is also simpler, when compared to other 
works, typically requiring several nanomaterials. 
3.3. Electrochemical response to other quinolone 
To response of the DNA gyrase biosensor was tested against another 
quinolone, to check its ability to respond to the quinolone, as expected 
when the mechanism of action of antibiotics is considered. Norfloxacin 
(NOR) was selected for this purpose, a commonly used fluoroquinolone 
antibacterial agent. The calibration was made as previously described 
for CIPRO, incubating NOR standard solutions of increasing concen-
trations for 30 min, and reading the EIS response in the presence of a 
standard iron redox probe. 
In general, the Nyquist plots evidenced increasing Rct values for 
increasing NOR concentrations (Fig. S2). The diameter of the semicircles 
increased after 30.2 nM, and lower concentrations lead to slight changes 
in the Rct values. The linear trend against the logarithm concentration of 
NOR has an average slope of 49.6 Ω/decade concentration and a mini-
mum squared correlation coefficient of 0.9905, from 30.2 nM to 0.302 
mM. Higher concentrations were tested, but the signal reached a satu-
ration after 0.302 mM (Fig. 4C). For calibrations produced with different 
biosensing units, the standard solutions yielded reproducible data, 
considering that RSD values were 3.9, 3.7% and 0.64%, for 0.302, 3.02 
and 30.2 µM, respectively. 
Comparing to CIPRO, the response of DNA gyrase to NOR was 
controlled for standard solutions that were 100× more concentred and 
underwent a saturation of the electrical signal at the same concentration 
level. In addition, the sensitivity of the response was about 89% of the 
response obtained for CIPRO. Thus, it was logical to assume that CIPRO 
displayed higher affinity to DNA gyrase then NOR. Interestingly, this is 
indeed consistent with the clinical treatments applied with these anti-
biotics. Although this depends on the bacterial strain and target appli-
cation, CIPRO may be used to treat urinary infections in short (3-day) 
periods and this is equally effective to longer treatments (7-day) with 
NOR [47]. 
3.4. Electrochemical response to a non-quinolone antibiotic 
In principal, the DNA gyrase biosensor is selective to quinolones, as 
this biological component of bacterial cells is their target. Thus, if a non- 
quinolone antibiotic compound is incubated on the sensing layer, it is 
expected that none or little binding may occur. To confirm this possi-
bility, the DNA gyrase biosensor was calibrated against AMP. This was 
done using the same conditions reported before for CIPRO and NOR 
calibrations. 
In general, EIS measurements (Fig. S3) evidenced negligible Rct 
changes for concentrations up to 30.2 µM. This confirmed the small 
affinity of AMP for DNA gyrase, as expected. Only concentrations higher 
than 0.302 mM were able to promote significant Rct changes, greater 
than 476.65 Ω. Moreover, the response in the lower concentration range 
where no significant increase was observed was quite table. It showed 
relative standard deviation values of 4.2, 2.4% and 0.96%, for 3.02 nM, 
0.302 µM and 3.02 µM, respectively. Overall, this supported its little 
effect of AMP in the range of concentration where CIPRO was 
responding (but AMP was not). Within the concentration range studied, 
no evidence of a linear response was observed for AMP. 
In practical terms, it was a fact that for high concentration of AMP 
the signal of the biosensor increased, meaning that this may be trans-
lated by a low concentration of CIPRO. To ensure that CIPRO is being 
read, it is important that two dilutions of the same sample are tested. If 
these differently diluted samples give rise to the same concentration in 
the original sample, than the slope of the calibration is corresponding to 
CIPRO. If the concentrations are too different, then another antibiotic 
may be involved in this analysis. In a completely different perspective, if 
the practical application for this biosensor would be to ensure that low 
levels of antibiotics are present in the waters, it is a good perspective that 
other antibiotics may be translated by the biosensor, even with smaller 
affinity and lower slopes. 
Overall, the response of the DNA gyrase biosensor against AMP 
confirmed the little affinity of DNA gyrase for AMP, while supporting the 
good selectivity of the electrochemical response for quinolones. The 
selectivity of the biosensor is addressed next.ure. 
3.5. Selectivity of the DNA gyrase biosensor 
Considering the responses obtained for CIPRO, NOR and AMP, it was 
possible to estimate the selectivity of the response of the DNA gyrase 
biosensor against the different antibiotics, from quinolones or non- 
quinolones. The relative responses of the electrodes to different con-
centrations are shown in Fig. 5. It confirms the good affinity of CIPRO 
and NOR to a DNA gyrase surface (0.302 µM and 30.2 µM), displaying 
similar sensitivity. This behaviour was clearly different from that of 
AMP, because this antibiotic is targeting the bacterial cell wall and, 
apparently, it does not have great affinity to DNA gyrase. Its response 
was also less reproducible. 
Urea and histamine were also tested as these may be present in 
contaminated waters. The signal produced by these species was very 
small, decreasing the blank signal by 8–10%. This indicated their small 
interfering effect upon the biosensor response. It is important to note 
that the tests made to monitor the affinity of urea and histamine for DNA 
gyrase had no competition between the main target analyte, which is 
CIPRO, and the interfering species. This suggests that in a real scenario, 
where the several species are competing for the same binding target, this 
interfering effect should be even smaller. Overall, the results obtained 
confirmed the good selectivity of the response of the biosensor. 
3.6. Comparison to an immunosensor 
As the DNA gyrase serves as a quantitative tool for members of the 
quinolone family, the quantitative determination of a single element of 
this family may require another approach. To provide this specific tool 
for CIPRO in this work, an immunosensor was prepared similarly, by 
Fig. 5. The absolute Rct values of the DNA gyrase biosensor obtained for the 
several antibiotics tested herein, in two concentration levels (0.302 µM and 
30.2 µM). 
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binding antibodies to the electrode surface instead of DNA gyrase. The 
antibodies used to this end were Ab-ENRO/CIPRO, as commercially 
available (no specific Ab-CIPRO was available). In brief, this was done 
by incubating the antibodies on the amine layer (Fig. 2F, as for the DNA 
gyrase) and adding BSA after to block non-specific binding (Fig. 2G), as 
typically done in other immunosensors [48]. The electrochemical data 
obtained throughout the chemical modifications involved in the as-
sembly of the immunosensor is presented in Fig. S4 and confirm the 
successful modification of the carbon surface. 
In order to establish a straight comparison with the DNA gyrase 
biosensor, this immunosensor was calibrated against CIPRO, NOR and 
AMP standard solution, under the same conditions use before. The re-
sults obtained are detailed next. 
3.6.1. Electrochemical response to Ciprofloxacin 
The EIS data produced by the incubation of CIPRO standard solutions 
on the immunosensor is detailed in Fig. 6. As expected, the Rct values 
increased for increasing concentrations, in a similar behaviour to that of 
the DNA gyrase biosensor (Fig. 6A). The sensitivity obtained for this 
response was also similar, equal to 55.6 Ω/decade concentration, with 
average squared correlation coefficients of 0.999. The linear response 
range was however narrower than that observed for the DNA gyrase 
biosensor, yielding linear responses from 30.2 nM to 0.302 mM 
(Fig. 6B). As in previous studies, the data obtained herein was repro-
ducible, considering that RSD values were 1.19, 2.30 and 3.06%, in 30.2 
nM, 0.302 µM and 3.02 µM, respectively. The LOD of the immunosensor 
was 11.3 nM. 
This response indicated that the DNA gyrase biosensor had similar 
sensitivity to the corresponding immunosensor and was able to show a 
linear response from lower concentrations. 
3.6.2. Electrochemical response to norfloxacin 
The EIS data obtained with NOR standard solutions is shown in 
Fig. S5 and was less sensitive than that obtained with CIPRO. This was as 
expected because antibodies were employed. However, it is important to 
highlight that the antibodies used herein were polyclonal and developed 
against enrofloxacin and ciprofloxacin, as obtained commercially. This 
meant that there could be a cross-response to other quinolone structure, 
as CIPRO, NOR and ENRO have significant structural similarities. 
Indeed, this was what happened, considering that the Rct increased 
slightly after incubating NOR, providing an average slope of 45.68 
Ω/decade (Fig. S5B) and an average squared correlation coefficient of 
0.9619. The linear response was however narrower, ranging from 30.2 
nM to 30.2 µM and RSD values obtained were 1.35 and 4.40%, in 30.2 
nM and 0.302 µM, respectively. 
3.6.3. Electrochemical response to a non-quinolone antibiotic 
The electrochemical response of the immunosensor against AMP is 
shown in Fig. S6A. It evidenced a slight response to AMP and a random 
response in the higher concentration level. This slight tendency to 
respond at lower concentrations was unexpected. 
To understand if this could be an adsorption to BSA, which was on 
the electrode surface to reduce non-specific binding, another immuno-
sensor was prepared without BSA coverage. The results of EIS mea-
surements evidenced a more intense response to the highest AMP 
concentrations (Fig. S6B), having steady signals at the lower concen-
tration level. Indeed, this result confirmed that the BSA was capable to 
reduce non-specific binding, because it reduced side-responses to higher 
concentrations, but it could also be responsible for the slight adsorption 
of AMP at the low concentration level, because without BSA there was 
no drift observed. Overall, when the surface was without BSA the drift in 
the lower concentration range was absent, but when BSA was present 
there was a slight drifting response to positive Rct changes. This would 
account the fact that when the surface was covered with BSA there was a 
huge amount of BSA when compared to the binding positions at the 
antibodies, which magnifies the effect of AMP adsorption to BSA. After 
saturation of the possible adsorption sites, the signal becomes random. 
Of course, there was always the possibility of a slight cross-response 
of the antibody because CIPRO, NOR and AMP have simple chemical 
structures (Fig. S1), with a common carboxylic function. Yet, under pH 
4, CIPRO and NOR have carboxyl groups that are mainly neutral, while 
AMP has this group mainly negatively charged. 
Interestingly, the slight drift caused by AMP was not observed in the 
DNA gyrase sensing, making the DNA gyrase biosensor an excellent way 
to monitor antibiotics of the quinolone group. 
4. Conclusion 
A novel sensor for CIPRO detection was successfully developed, by 
employing as biorecognition element its biological target in bacteria, 
immobilizing DNA gyrase on the working electrode of C-SPEs modified 
with carboxylated carbon nanotubes. Comparing to other works, 
Fig. 6. Nyquist plots (A) of the redox probe 5.0 × 10− 3 M [Fe(CN)6]3− /[Fe(CN)6]4− read in DNAG gyrase biosensors that were incubated for 30 min in CIPRO 
standard solutions of increasing concentrations, prepared in 0.1 M acetate buffer, pH4.0, and the corresponding calibration curve plots (B). 
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[24,27,29–31], as detailed in Table S2, this approach offered the 
advantage of being simple and effective, ensuring a wider linear con-
centration range of response. This wide linear range allows simplifying 
the sample pre-treating stage, something that is especially important 
when the concentration level of a given analyte is unknown. As DNA 
gyrase is targeted by quinolones in general, the response of the biosensor 
to NOR was also validated, although revealing slightly lower sensitivity 
and thereby slightly lower affinity. The ability of DNA gyrase to selec-
tively detect quinolones was confirmed by checking the response of the 
biosensor to AMP and confirming its random response. 
The analytical response was also compared to that of an immuno-
sensor prepared similarly. Interestingly, the best analytical features 
were obtained using the DNA gyrase as biorecognition element. This is 
likely related to the fact that DNA gyrase sensing layer has more binding 
points than the antibody sensing layer, in which the antibodies were 
immobilized first, and their non-specific response was after reduced by 
incubating BSA (a typical procedure among immunosensors). 
Overall, the new design presented herein offers advantageous fea-
tures in terms of analytical performance and enables readings for 
different antibiotics among the same group. This concept may be 
extended to introduce additional insights into the mechanistic action of 
antibiotics. When in environmental conditions, it is important that the 
temperature is monitored, as it my influence the electrochemical read-
ings; the system could need additional testing under different temper-
atures to understand which calibration applies to a given temperature. 
Regarding reproducibility, it was interesting to note that different bio-
sensing units showed behaviour among each other, especially at the 
stage of the carbon nanotube modification, which was a common point 
among all assemblies. In these, the average Rct values was 66.2 Ω and 
the RSD was 2.7%. 
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